Historical aspects
The first reports of Nasu-Hakola syndrome (NHS) are attributed to Terayama' in 1961 and Jarvi et af in 1964, but the eponym recognises the major contributions to the delineation of the phenotype of Hakola,' who described nine patients from seven Finnish families in 1972, and Nasu et al,4 who almost simultaneously reported one Japanese patient (and indeed diagnosed the patient reported by Terayama' ). The disorder is often (but cumbersomely) termed polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy in Finnish publications and membranous lipodystrophy by Japanese authors.
Illustrative case report The patient is the only male child of a Belgian mother (father unknown), born in 1948, without known ancestry from northern Europe. The first stage of the disease was characterised by multiple quasi-spontaneous fractures of the extremities beginning at the age of 26, initially affecting the carpal and tarsal bones and later the tibiae and femora. Steatorrhoea appeared at the age of 41 . Disturbances of mood appeared in his late thirties, followed by a rapid deterioration first noted at 40 years; there were loss of social skills, aberrant or manic behaviour, incontinence, aggressiveness, loss of memory, and confabulations. Within one year, dementia became obvious and he became bedridden and unconscious. Right focal, secondarily generalised seizures appeared. Death occurred at the age of 45 years. Permission for necropsy was refused.
Neurological assessment at the age of 42 was basically normal; there were no pyramidal or cerebellar signs, but mild apraxia, dyscalculia, and spatial disorientation. Psychiatric assessment suggested frontal dysfunction (decreased verbal fluency, perseveration, poor memory, loss of social inhibitions, and confabulation). Folstein's mini mental score was clearly in the dementia range. IQ was 54 (WAIS). EEG showed a persistent basal rhythm with posterior theta and slow waves (7) (8) . CT scan showed slight hemispheric atrophy. PET scan with ['8F] fluorodeoxyribose showed a normal global glucose metabolic rate (4.69 ± 0.65 mg/100 g/min). Regionally, the highest levels were in the occipital lobes, whereas they were lower in the frontal, temporal, and parietal regions and in the thalamic nuclei, and markedly decreased in the medial frontal area and basal ganglia.5 Major steatosis of the liver was observed.
Epidemiology and genetics
The disorder has been observed in fewer than 150 cases (because of multiple reports of some patients, and of unpublished, but quoted cases, precise counting is difficult). Most cases come from two widely separated groups, the Japanese and the Finnish population of northern Scandinavia. At least 84 cases have been identified in Japan,4 "27 30 Our illustrative patient appears to be the first case of this uncommon disease from western Europe.
NHS is clearly recessive and affects both sexes equally. Consanguinity has been observed in several instances.3 10 11 13 21 There is no genetic mapping information at present. 
